Profile
Senior financial director with proven excellence in strategic financial management, with a focus on delivering commercially-oriented financial leadership to optimize business value.
Nearly 20 years’ experience in U.S., European and global financial management, with 12 years within the pharmaceutical industry. Areas of focus include: strategic planning, value enhancement, revenue and performance analysis, forecasting, general accounting and financial reporting. Experienced in both direct and indirect team management.
Professional Experience
UNIVERSITY OF LATVIA Riga, Latvia
2014 – 2016
M.Soc.Sc. Candidate, European Studies: EU External Relations – Eastern Europe and Russia
PFIZER, INC. New York, NY and London, UK
2001 – 2014
Senior Finance Business Partner, UK Specialty Care Business Unit (SCBU) (2011 – 2014)
Responsible for leading UK SCBU finance team delivering financial direction and leadership to the UK Specialty Care Business Unit leadership team while ensuring strict compliance with all accounting principles and policies. Strong focus on country-regional collaboration and alignment as well as value optimization within a financially dynamic environment.
• Led annual Strategic Operating Plan process
• Led revenue analysis and P&L performance review and enhancement
• Delivered financial insight and strategic guidance to UK leadership team to enable commercial decision making
• Proactively identified areas of improvement and implemented new metrics
• Led forecasting process for all UK SCBU brand teams, involving intensive leadership of and collaboration with finance center of excellence and regional finance team
• Led implementation in UK and across Europe for new budgeting and forecast development tool; responsible for driving significant additional enhancements
Finance Director, US Primary Care Business Unit, Southeast Region
2008 – 2011
Responsible for delivering financial direction and leadership to the US Southeast Region Business Unit leadership team while ensuring strict compliance with all accounting principles and policies. Strong focus on regional-HQ collaboration and alignment as well as value optimization within a financially dynamic environment.
• During RBU structure creation (2008), directly responsible for developing revenue and expense budgets, reporting practices for RBU and state level as well as structure development of overall finance processes
• Due to staffing constraints and maternity leave, in addition to primary role, served as:
o Interim Finance Director for Western RBU (16 states)
o Interim Finance Director for Corporate and Government Customers BU
• Led annual Strategic Operating Plan process within RBU
• Led development of forecasts for RBU across primary care product portfolio
• Responsible for ad-hoc financial and analytical deliverables to RBU President and leadership team
Finance Director, U.S. Pharmaceuticals Customer Business Unit
2008
Responsible for delivering financial direction to the Customer Business Unit while ensuring strict compliance with all accounting principles and policies. Strong focus on HQ collaboration and alignment as well as value optimization within a financially dynamic environment. Key areas of focus included leadership of strategic operating plan, expense performance analysis and interpretation, forecasting.
Senior Manager, U.S. Government Pricing
2006 – 2008
Responsible for financial support for U.S. Government pricing programs and engaging with Center for Medicare and Medicate Services and Office of Pharmacy Affairs. Areas of focus included preparation of monthly/quarterly government prices (Average Manufacturer Price, Best Price, Average Selling Price and 340B pricing), CMS reporting and analysis of impact of legislative changes. Supported internal and external audits.
• Key member of team responsible for enhancement of Government Pricing System
• Reviewed and updated Standard Operating Procedures (SOPs)
• Promoted to Finance Director in recognition of excellent performance
Senior Manager, Global Financial Operations
2004 – 2006
Responsible for delivering accurate and timely monthly financial reporting for Pfizer’s Human Health Division (PHH). Responsible for developing operating plan guidelines, consolidated operating plan financial data and submission for OP&A. Assisted in Beacon User Acceptance training process.
• Led development and execution of new reporting for Hyperion Financial Management System (HFM)
• Led Adapting-to-Scale (AtS) initiative for PHH, engaging with multiple cross-functional teams and resulting in the development of new Human Health Cost Base.
• Led review of quarterly external reporting and press releases and developed monthly commentary for Board of Directors.
Sr. Associate/ Manager, Marketing Finance
2002 – 2004
Responsible for financial management of Ellence and Aromasin assets, including sales and expense forecasting, US sales models, operating planning and IMS reporting. Developed demand-based model for Ellence and served on global team tasked with developing NPV analysis for Aromasin Depot formulation. Supported Finance Manager for Celebrex and Bextra assets. Areas of focus included budget preparation, development of quarterly expense forecasts and creation of monthly revenue and sales report. Served as financial lead for Cardura asset; responsible for sales/expense forecasting including out-licensing initiatives, sales modeling, NPV analysis and operating plan development.
References
And details on positions from 1995 – 2002 available upon request.
Education
2016 M.Soc.Sc, European Studies, University of Latvia (Riga, Latvia) – degree expected June 2016
2004 M.B.A., Marketing, Long Island University (Brooklyn, NY)
1995 B.S., Financial Management/Accounting, Clemson University (Clemson, SC)
Languages
English (native speaker), Latvian (basic), Spanish (basic) and French (basic)
